Dose-surface analysis for prediction of severe acute radio-induced skin toxicity in breast cancer patients

References

• Lopez E, Nunez MI, Guerrero MR, del Moral R, de Dios Luna J, del Mar Rodriguez M, et al. Breast cancer acute radiotherapy morbidity evaluated by different scoring systems. Breast Can Res Treat 2002;73:127–34.
   PubMed Web of Science ®Google Scholar
• Hymes SR, Strom EA, Fife C. Radiation dermatitis: clinical presentation, pathophysiology, and treatment 2006. J Am Acad Dermatol 2006;54:28–46.
   PubMed Web of Science ®Google Scholar
• Leonardi MC, Morra A, Santoro L, Balduzzi A, Ivaldi GB, Vischioni B, et al. Nonrandomized comparison between concomitant and sequential chemoradiotherapy with anthracyclines in breast cancer. Tumori 2015;101:64–71.
   PubMed Web of Science ®Google Scholar
• Kraus-Tiefenbacher U, Sfintizky A, Welzel G, Simeonova A, Sperk E, Siebenlist K, et al. Factors of influence on acute skin toxicity of breast cancer patients treated with standard three-dimensional conformal radiotherapy (3D-CRT) after breast conserving surgery (BCS). Radiat Oncol. 2012;7:217.
   PubMed Web of Science ®Google Scholar
• Yamazaki H, Yoshida K, Nishimura T, Kobayashi K, Tsubokura T, Kodani N, et al. Association between skin phototype and radiation dermatitis in patients with breast cancer treated with breast-conserving therapy: suntan reaction could be a good predictor for radiation pigmentation. J Radiat Res. 2011;52:496–501.
   PubMed Web of Science ®Google Scholar
• Bentzen SM, Overgaard M. Relationship between early and late normal-tissue injury after postmastectomy radiotherapy. Radiother Oncol 1991;20:159–65.
   PubMed Web of Science ®Google Scholar
• Dorr W, Hendry JH. Consequential late effects in normal tissues. Radiother Oncol. 2001;61:223–31.
   PubMed Web of Science ®Google Scholar
• Rubin P, Milano MT, Constine LS. ALERT - Adverse Late Effects of Cancer Treatment: Volume 2: Normal Tissue Specific Sites and System. Luther W, Brady H-PH, Michael Molls, Carsten Nieder, editor 2013.
   Google Scholar
• Alexander MA, Brooks WA, Blake SW. Normal tissue complication probability modelling of tissue fibrosis following breast radiotherapy. Phys Med Biol. 2007;52:1831–43.
   PubMed Web of Science ®Google Scholar
• Avanzo M, Stancanello J, Trovo M, Jena R, Roncadin M, Trovo MG, et al. Complication probability model for subcutaneous fibrosis based on published data of partial and whole breast irradiation. Phys Med. 2012;28:296–306.
   PubMed Web of Science ®Google Scholar
• Mukesh MB, Harris E, Collette S, Coles CE, Bartelink H, Wilkinson J, et al. Normal tissue complication probability (NTCP) parameters for breast fibrosis: pooled results from two randomised trials. Radiother Oncol 2013;108:293–8.
   PubMed Web of Science ®Google Scholar
• Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 1988;124:869–71.
   PubMed Web of Science ®Google Scholar
• Kupetsky EA, Keller M. Psoriasis vulgaris: an evidence-based guide for primary care. J Am Board Fam Med. 2013;26:787–801.
   PubMed Web of Science ®Google Scholar
• Pacelli R, Conson M, Cella L, Liuzzi R, Troncone G, Iorio V, et al. Radiation therapy following surgery for localized breast cancer: outcome prediction by classical prognostic factors and approximated genetic subtypes. J Radiat Res. 2013;54:292–8.
   PubMed Web of Science ®Google Scholar
• Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341–6.
   PubMed Web of Science ®Google Scholar
• Deasy JO, Blanco AI, Clark VH. CERR: a computational environment for radiotherapy research. Med Phys 2003;30:979–85.
   PubMed Web of Science ®Google Scholar
• Cella L, Palma G, Deasy JO, Oh JH, Liuzzi R, D'Avino V, et al. Complication probability models for radiation-induced heart valvular dysfunction: do heart-lung interactions play a role? PLoS One. 2014;9:e111753.
   PubMed Web of Science ®Google Scholar
• Cella L, Liuzzi R, Conson M, D'Avino V, Salvatore M, Pacelli R. Development of multivariate NTCP models for radiation-induced hypothyroidism: a comparative analysis. Radiat Oncol. 2012;7:224.
   PubMed Web of Science ®Google Scholar
• El Naqa I, Suneja G, Lindsay PE, Hope AJ, Alaly JR, Vicic M, et al. Dose response explorer: an integrated open-source tool for exploring and modelling radiotherapy dose-volume outcome relationships. Phys Med Biol 2006;51:5719–35.
   PubMed Web of Science ®Google Scholar
• Archambeau JO, Pezner R, Wasserman T. Pathophysiology of irradiated skin and breast. Int J Radiat Oncol Biol Phys 1995;31:1171–85.
   PubMed Web of Science ®Google Scholar
• Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991;21:109–22.
   PubMed Web of Science ®Google Scholar
• Hopewell JW. Mechanisms of the action of radiation on skin and underlying tissues. Br J Radiol Suppl. 1986;19:39–47.
   PubMedGoogle Scholar
• Perera GK, Di Meglio P, Nestle FO. Psoriasis. Ann Rev Pathol. 2012;7:385–422.
   PubMed Web of Science ®Google Scholar
• Seibold P, Behrens S, Schmezer P, Helmbold I, Barnett G, Coles C, et al. XRCC1 polymorphism associated with late toxicity after radiation therapy in breast cancer patients. Int J Radiat Oncol Biol Phys 2015;92:1084–92.
   PubMed Web of Science ®Google Scholar
• Andreassen CN. Can risk of radiotherapy-induced normal tissue complications be predicted from genetic profiles? Acta Oncol. 2005;44:801–15.
   PubMed Web of Science ®Google Scholar